Plain-English translation of NCT07321652 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial compares two ways of treating chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in older adults who have never received treatment before. Some patients will take alone, while others will take combined with . The goal is to see whether adding the new medication helps people stay cancer-free longer.
Doctors want to find better ways to treat these blood cancers in older patients. This medication combination may work better than the current standard treatment, potentially giving patients longer periods without their cancer returning.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic regularly to receive your assigned medication by mouth, either alone or plus . You will have blood tests and bone marrow samples taken throughout the study to see how well the treatment is working. The trial lasts about 2 years, and you may stop treatment earlier if your cancer disappears completely or if the treatment isn't working.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States